# Assessing the Benefits of a Painless Lancing Device Among Diabetes Patients

Study · id `cardio:ct-nct04214704` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04214704](<https://clinicaltrials.gov/study/NCT04214704>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04214704

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.

## Technical summary

Registry record NCT04214704. Randomized; no masking; primary purpose treatment. Start 2020-02-04 (actual); primary completion 2021-07-15 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 110 participants (enrolled count; ClinicalTrials.gov record NCT04214704, source copy `cardio:ctgov-nct04214704-2021-07-29`, retrieved 2026-10-26)
- Started: 2020-02-04 (actual) (ClinicalTrials.gov record NCT04214704, source copy `cardio:ctgov-nct04214704-2021-07-29`, retrieved 2026-10-26)
- Primary completion: 2021-07-15 (actual) (ClinicalTrials.gov record NCT04214704, source copy `cardio:ctgov-nct04214704-2021-07-29`, retrieved 2026-10-26)
- Completion: 2021-07-15 (actual) (ClinicalTrials.gov record NCT04214704, source copy `cardio:ctgov-nct04214704-2021-07-29`, retrieved 2026-10-26)
- Countries: India (ClinicalTrials.gov record NCT04214704, source copy `cardio:ctgov-nct04214704-2021-07-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04214704-2021-07-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: Assessing the Benefits of a Painless Lancing Device Among Diabetes Patients
- Condition: Type 1 Diabetes
- Condition: Type 2 Diabetes
- Intervention (Device): Genteel lancing device
- Intervention (Device): Conventional lancing device
- Lead sponsor: Jothydev's Diabetes and Research Centre
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)

## Provenance

Content hash: e8bb29bf4c83637b8c242dfcc633d1d82ba7235c1dcfd7a828fcc510c252144e
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
